are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

TRIUMEQ (abacavir, dolutegravir, and lamivudine tablets)

TRIUMEQ (abacavir, dolutegravir, and lamivudine tablets)

TRIUMEQ contains an INSTI (dolutegravir) and 2 nucleoside analogues (abacavir and lamivudine) with inhibitory activity against HIV. TRIUMEQ is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients weighing at least 40 kg.

Abacavir and Lamivudine Tablets USP

Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.